Australia's most trusted
source of pharma news
Sunday, 02 November 2025
Sunday, 2 November 2025
Subscribe
Login
News Headlines
News Headlines
News
Novartis seals $18B mega buyout
Posted 28 October 2025 AM
Novartis is strengthening its neuromuscular portfolio with an $18.4 billion (US$12 billion) acquisition of Avidity Biosciences for its next-generation antibody-oligonucleotide conjugates.
It's the second largest pharma acquisition of the year, just behind J&J's purchase of Intra-Cellular Therapies in January. The deal gives Novartis three potential first-in-class late-stage clinical assets targeting neuromuscular diseases by linking various oligonucleotides to muscle-specific antibodies (AOCs). The merger is expected to close in the first half of 2026.
To see the whole article, please login
Posted 28 October 2025 AM
Novartis is strengthening its neuromuscular portfolio with an $18.4 billion (US$12 billion) acquisition of Avidity Biosciences for its next-generation antibody-oligonucleotide conjugates.
It's the second largest pharma acquisition of the year, just behind J&J's purchase of Intra-Cellular Therapies in January. The deal gives Novartis three potential first-in-class late-stage clinical assets targeting neuromuscular diseases by linking various oligonucleotides to muscle-specific antibodies (AOCs). The merger is expected to close in the first half of 2026.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (4)
- Brand Manager - Melbourne
- Senior Product Manager - Sydney
- Associate Brand Manager - Sydney
- Associate Brand Manager - Sydney
Sales & Customer Relations (13)
- Customer Service Representative - Macquarie Park
- Key Account Manager - Sydney
- Customer Service Representative - Macquarie Park
- GP Sales Representative - NSW Mid North Coast - AstraZeneca - NSW
- GP Sales Representative - Cronulla - AstraZeneca - Cronulla, NSW
- Key Account Manager - Melbourne
- GP Sales Representative - Brisbane North - Flexible 3 Days - AstraZeneca - Brisbane
- GP Sales Representative - Sydney
- Customer Service Representative - St Leonards
- Key Account Manager - Renal Metabolic - Adelaide - AstraZeneca - Adelaide, SA
- GP Sales Representative - Adelaide South - AstraZeneca - Adelaide, SA
- GP Sales Representative - Bundaberg, QLD - AstraZeneca - Bundaber, QLD
- Territory Manager - Melbourne
Clinical & Medical, R&D (7)
- Clinical Affairs Lead - Sydney
- QC Microbiologist - Broadmeadows
- QC Scientist - 40120 - Broadmeadows
- Medical Director - Sydney
- QCE Scientist Instrumentation (GDIP) - Broadmeadows
- Medical Advisor - Sydney
- Medical Advisor - Sydney
Regulatory, Pharmacovigilance & QA (3)
- Pharmacovigilance Associate - Sydney
- Quality assurance associate - Sydney
- Regulatory Affairs Associate - Sydney
Other (11)
- Technical Service & Warehouse Coordinator - Alexandria
- Service Administrator - Belrose
- Warehouse & Logistics Officer - Macquarie Park
- Financial Reporting Manager - Macquarie Park
- Financial Analyst - Melbourne
- Senior Manager - Cell Therapy - Australia - AstraZeneca - Sydney or Melbourne
- Finance Business Partner - Surry Hills
- Logistics Specialist - Macquarie Park
- Senior Recruitment Consultant - Victoria
- Financial Analyst - Melbourne
- Senior Recruitment Consultant - Sydney
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.